Key points
- The Dengvaxia dengue vaccine requires three doses for full protection.
- The vaccine doses are given 6 months apart.
- Dengvaxia is administered subcutaneously.
![A line of vials containing clear liquid on a blue background.](https://www.cdc.gov/dengue/media/images/vax-schedule-and-dosing.png)
Details
- Requires mixing of diluent and lyophilized vaccine antigen in single use vials
- 0.5 mL per dose
- Subcutaneous injection
- Three-dose series, given 6 months apart
Co-administration
Trials have evaluated co-administration of Dengvaxia with other vaccines, including yellow fever, diphtheria, tetanus, acellular pertussis (DTaP), inactivated polio, Haemophilus influenzae types b and a, and measles, mumps, and rubella (MMR). No safety issues have been reported.
Vaccine providers should follow best practice guidance from the Advisory Committee on Immunization Practices, which states that injectable, live-attenuated vaccines not administered simultaneously should be separated by at least 4 weeks.